filmov
tv
HDSA RESEARCH WEBINAR: All You Need To Know About PROOF-HD
Показать описание
On Wednesday, September 7, 2022, Dr. Michael Hayden, CEO of Prilenia, along with Drs. Andy Feigin and Sandra Kostyk, provided an overview and insights into the progress of PROOF-HD, a global, Phase 3 study evaluating pridopidine for the treatment of #HuntingtonsDisease.
#LetsTalkAboutHD #HDSAFamily
#LetsTalkAboutHD #HDSAFamily
HDSA RESEARCH WEBINAR: All You Need To Know About PROOF-HD
HDSA Research Webinar: PROOF-HD
HDSA RESEARCH WEBINAR: The PREVENT-HD Study
HDSA RESEARCH WEBINAR: Ask the Scientists...Anything!
HDSA RESEARCH WEBINAR: Understanding Brain Development
HDSA RESEARCH WEBINAR: The Power of Medical Records in #HuntingtonsDisease Research
HDSA RESEARCH WEBINAR: Novartis Discusses the VIBRANT-HD Trial
RESEARCH WEBINAR: KINECT-HD
RESEARCH WEBINAR: HDSA & the HD Research Pipeline
HDSA RESEARCH WEBINAR: Ask the Scientist... Anything!
HDSA RESEARCH WEBINAR: Update from PTC Therapeutics on the PIVOT-HD Trial
HDSA RESEARCH WEBINAR: HD Clinical Trial Update
HDSA RESEARCH WEBINAR: Brain Imaging Biomarkers for Huntington's Disease
RESEARCH WEBINAR: HD Research Year in Review
RESEARCH WEBINAR: New Insights on HD Age of Onset with Dr. James Gusella
WEBINAR: DNA Repair in Huntington's Disease
HDSA RESEARCH WEBINAR: 2019 Year in Review
HSC x HDSA Research Webinar: Data from the Phase 3 PROOF HD Trial of Pridopidine
Webinar: Exercise for the Brain & Body: The Benefits of Physical Activity in HD
RESEARCH WEBINAR: Neural Stem Cells as a Therapeutic Candidate for Huntington's Disease
QUICK QUESTION: How do I get involved in #HuntingtonsDisease research?
WEBINAR: Huntington's Disease Research 2018 Year in Review
Ask the Scientist...ANYTHING!
Research Webinar: FIRST HD
Комментарии